LGR5 and metastatic neoplasm: Similar results were described by Wu et al.32 showing that high expression levels of LGR5 receptors were usually associated with more biologically aggressive, advanced and metastatic tumors and that LGR5 is related to worse prognosis in patients with CRC.32